BioSpace News Archive

AgileOne, a total talent management leader, is the new provider of record for contingent workforce management for Bristol-Myers Squibb, a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases, AgileOne announced today

Applications are now open for press accreditation to the announcements at the Royal Swedish Academy of Sciences. Every year, the Academy awards the Nobel Prizes in Physics and Chemistry, and the Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel.

Cardiovascular BioTherapeutics, Inc., (“CVBT,” the “Company”). CVBT is pleased to announce the appointments of David M. Ornitz, MD, PhD and Dr. Arnold I. Chin, MD, PhD.

hildren’s National Health System has acquired the latest virtual reality surgical system from Surgical Theater, a leading provider of the FDA-approved breakthrough technology for healthcare

The British Heart Foundation (BHF) is today launching the Big Beat Challenge, a unique research funding award that will bring together world-leading researchers and innovators to identify and solve any of the biggest problems in heart and circulatory disease.

First responders to major chemical exposure incidents in the United States can improve treatment protocols for at-risk casualties with better communication strategies, according to new analysis in Annals of Emergency Medicine.

MDxHealth SA (Euronext: MDXH.BR) worldwide leading in molecular diagnostics for urologic cancers, today announces that a study validating the cost-effectiveness of SelectMDx for Prostate Cancer, a non-invasive ‘liquid biopsy’ test to identify patients at increased risk of aggressive prostate cancer, has been published online by the journal Prostate Cancer and Prostatic Diseases.

BC Platforms, a world leader in genomic data management and analytics, today announces that it has partnered with Proteus Genomics, a clinical reference lab specializing in pharmacogenomics, to streamline genomic and healthcare data integration.

Technavio analysts forecast the global thalassemia drugs market to grow at a CAGR of close to 10% during the forecast period, according to their latest market research report.

Next-Generation Balloon Microcatheters Now Commercially Available in Europe